All Posts: SARS-CoV-2

• Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer

  WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]

  Category: News Release Tags: cancer, cancer research, COVID-19, SARS-CoV-2